Vol. 16 No. 3 (2016)

Published: 2016-09-18

Editorials

The American Diabetes Association’s new standards for diabetes care

Paul Grant

99-100
- HTML
- PDF
Why should you commission structured patient education for adults with type 1 diabetes?

Helen Hopkinson

101-102
- HTML
- PDF
Diabetes medications with cardiovascular protection – what now after LEADER®? Could metformin, pioglitazone, empagliflozin and liraglutide complement each other to save lives?

Robert EJ Ryder, Ralph A DeFronzo

103-106
- HTML
- PDF

Reviews

Obstructive sleep apnoea: a diabetologist’s perspective

Abd A Tahrani

107-113
- HTML
- PDF
Stroke and diabetes: a dangerous liaison

Sarah L Macpherson, Christopher R R Sainsbury, Jesse Dawson, Gregory C Jones

114-118
- HTML
- PDF

Original Research

Diabetes should not dissuade arteriovenous fistula formation

Andrew C Gordon, Sham Dholakia, Damien Ashby, Jeremy s Crane

119-122
- HTML
- PDF

Current Topics

The use of glucose measurements to improve screening for diabetes in clinical practice

Adam R Nicholls, Dankmar Böhning, Richard Holt, Patrick Sharp

123-127
- HTML
- PDF
Glucagon like peptide-1 receptor agonist (GLP-1RA) therapy in management of type 2 diabetes: choosing the right agent for individualised care

Zin Zin Htike, Francesco Zaccardi, Sudesna Chatterjee, Kamlesh Khunti, Melanie J Davies

128-137
- HTML
- PDF

Case Reports

Combining SGLT2 inhibitor and GLP-1 agonist: exaggerated weight loss in a morbidly obese patient with type 2 diabetes

Kg Nilwala U Jayasinghe, Veronica J Greener, Michael D Feher

138-139
- HTML
- PDF

Meeting Reports

ABCD Spring Meeting, Renaissance Manchester Hotel, 21–22 April 2016, in conjunction with the North West Endocrine Society

Rob Gregory

140-141
- HTML
- PDF
Highlights from the 76th Scientific Sessions of the American Diabetes Association

Caroline Day

141-142
- HTML
- PDF

ABCD News

ABCD News

Umesh Dashora

143-148
- HTML
- PDF